Invitation to industry sessions

www.ecnp.eu

Invitation to industry sessions

The invitation leaflets of the industry sessions of the 32nd ECNP Congress are published below.

Saturday 7 September

	Satellite Symposium C.01 – Bipolar disorder & pregnancy 12.15-13.45, Auditorium 15 Educational financial support provided by Sanofi

	Satellite Symposium C.02 – Managing adult ADHD patients with psychiatric comorbidity 12.15-13.45, Room C1 Educational financial support provided by Takeda/Global Medical Education

	Satellite Symposium C.03 – Patient centricity in depression: how to measure what is most important? 12.15-13.45, Room C4 Educational financial support provided by H. Lundbeck A/S

	Satellite Symposium C.04 – Improving outcomes of schizophrenia with long-acting antipsychotic treatment: impact on patients and carers 14.45-16.15, Auditorium 15 Educational financial support provided by Janssen Pharmaceutica NV

	Satellite Symposium C.06 – Demystifying common issues in major depressive disorder: recognise and act! 14.45-16.15, Room C4 Educational financial support provided by Medscape Psychiatry (unrestricted grant from H. Lundbeck A/S)

Sunday 8 September

	Expert Science Exchange CE.01 – Who is at risk of what? What we can learn from register data about patients with ADHD and their outcomes 09.00-10.00, Room C3 Financial support provided by MEDICE Arzneimittel

	Expert Science Exchange CE.02 – Emotional functioning in major depressive disorder: unresolved symptom or side effect? 10.00-11.00, Room C2 Financial support provided by H. Lundbeck A/S

	Innovation Showcase IN.01 – Postpartum depression: how does it really feel? 12.00-12.30, The Bubble Financial support provided by Sage Therapeutics, Inc.

	Expert Science Exchange CE.03 – How do you approach the treatment of depressive episodes today? What pathways are thought to play a role in depression? 15.15-16.15, Room C3 Financial support provided by Sage Therapeutics, Inc.

	Satellite Symposium C.07 – Are relapse prevention and functioning sufficiently prioritised in the treatment of schizophrenia? 17:30 - 19:00, Hall A2 Educational financial support provided by H. Lundbeck A/S

	Satellite Symposium C.09 – Patient functioning in schizophrenia: can we change the burden? 17.30-19.00, Room C1 Educational financial support provided by Gedeon Richter Plc & RECORDATI S.p.A

	Satellite Symposium C.12 – Major depressive disorder (MDD) treatment: from biological basis to patient reality 17.30-19.00, Room C4 Educational financial support provided by Janssen Pharmaceutica NV

Monday 9 September


	Expert Science Exchange CE.04 – How do you approach the treatment of depressive episodes today? What pathways are thought to play a role in depression? 09.00-10.00, Room C3 Financial support provided by Sage Therapeutics, Inc.

	Expert Science Exchange CE.05 – Targeting mental health disorders to reduce the burden of noncommunicable chronic diseases 10.00-11.00, Room C2 Financial support provided by Upjohn, A Pfizer Division
	Innovation Showcase IN.02 – What can we expect from an antidepressant with a multimodal activity in the treatment of major depressive disorder? 12.00-12.30, The Bubble Financial support provided by H. Lundbeck A/S

	Expert Science Exchange CE.06 – Discovering ADHD in adults 15.15-16.15, Room C3 Financial support provided by Takeda

	Expert Science Exchange CE.07 – Discovering ADHD in adults 16.15-17.15, Room C3 Financial support provided by Takeda

	Satellite Symposium C.10 – Patient perspectives on treatment outcomes and goals in schizophrenia 17.30-19.00, Hall A2 Educational financial support provided by H. Lundbeck A/S

	Satellite Symposium C.11 – Transition in schizophrenia: symptoms, treatments and diagnosis - challenges from adolescence to adulthood 17.30-19.00, Auditorium 15 Educational financial support provided by Sunovion Pharmaceuticals Inc., Sumitimo Dainippon Pharma Co. Ltd. and Angelini

Satellite Symposium (C)
These scientifically oriented sessions are organised by and with educational financial support from industry. The programmes have been reviewed for balance and rigour by the Scientific Programme Committee. These sessions might be accredited for European accreditation (CME) depending on the industry organising the satellite symposium.

Expert Science Exchange (CE)
The expert science exchange sessions provide the opportunity for focused, scientifically driven engagement between industry and a small group of participants.
Each session is 60 minutes and has a limited capacity of 80 participants. Admittance is given on a first-come-first-served basis. The sessions are organised and financially supported by industry. These sessions do not come with CME credits.

Innovation Showcase (INS)
These hands-on, interactive sessions provide a high-value forum for industry to engage with a small group of participants on a broad range of issues, including treatment approaches, the uses of specific medications, clinical insights, and product demonstrations. Each Innovation Showcase Session has a limited capacity. Admittance is given on a first-come-first-served basis. The sessions are organised and financially supported by industry. These sessions do not come with CME credits.

For the detailed programme, including abstracts and a short biography of most of the speakers, click here.